相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pim-1 controls NF-κB signalling by stabilizing RelA/p65
K. Nihira et al.
CELL DEATH AND DIFFERENTIATION (2010)
Potential utility of small tyrosine kinase inhibitors in the treatment of diabetes
Dariush Mokhtari et al.
CLINICAL SCIENCE (2010)
Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes
M. Igoillo-Esteve et al.
DIABETOLOGIA (2010)
Plasma Adiponectin Levels Are Markedly Elevated in Imatinib-Treated Chronic Myeloid Leukemia (CML) Patients: A Mechanism for Improved Insulin Sensitivity in Type 2 Diabetic CML Patients?
Stephen Fitter et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
A Protein Tyrosine Kinase Inhibitor, Imatinib Mesylate (Gleevec), Improves Erectile and Vascular Function Secondary to a Reduction of Hyperglycemia in Diabetic Rats
Serap Gur et al.
JOURNAL OF SEXUAL MEDICINE (2010)
The Scaffold Protein TANK/I-TRAF Inhibits NF-κB Activation by Recruiting Polo-like Kinase 1
Wanqiao Zhang et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
Imatinib does not substantially modify the glycemic profile in patients with chronic myeloid leukaemia
Stefania Mariani et al.
LEUKEMIA RESEARCH (2010)
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Jeffrey A. Bluestone et al.
NATURE (2010)
Regulation of NF-κB by NSD1/FBXL11-dependent reversible lysine methylation of p65
Tao Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cytokine production by islets in health and diabetes: cellular origin, regulation and function
Marc Y. Donath et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Overexpression of the nuclear factor-κB subunit c-Rel protects against human islet cell death in vitro
Dariush Mokhtari et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Nuclear NF-κB p65 Phosphorylation at Serine 276 by Protein Kinase A Contributes to the Malignant Phenotype of Head and Neck Cancer
Pattatheyil Arun et al.
CLINICAL CANCER RESEARCH (2009)
Imatinib Mesylate Reduces Endoplasmic Reticulum Stress and Induces Remission of Diabetes in db/db Mice
Myoung Sook Han et al.
DIABETES (2009)
Rac1 regulates peptidoglycan-induced nuclear factor-κB activation and cyclooxygenase-2 expression in RAW 264.7 macrophages by activating the phosphatidylinositol 3-kinase/Akt pathway
Bing-Chang Chen et al.
MOLECULAR IMMUNOLOGY (2009)
Ser276 Phosphorylation of NF-κB p65 by MSK1 Controls SCF Expression in Inflammation
Laurent Reber et al.
PLOS ONE (2009)
NF-κB activity is constitutively elevated in c-Abl null fibroblasts
Rachel A. Liberatore et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Potential of Small Molecule Protein Tyrosine Kinase Inhibitors as Immunomodulators and Inhibitors of the Development of Diabetes
Peter J. Little et al.
THESCIENTIFICWORLDJOURNAL (2009)
Imatinib mesylate improves insulin sensitivity and glucose disposal rates in rats fed a high-fat diet
Robert Hagerkvist et al.
CLINICAL SCIENCE (2008)
Restoration of insulin sensitivity following treatment with imatinib mesylate (Gleevec) in non-diabetic patients with chronic myelogenic leukemia (CML)
Apostolos Tsapas et al.
LEUKEMIA RESEARCH (2008)
Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinib
M. Breccia et al.
LEUKEMIA RESEARCH (2008)
Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice
Cedric Louvet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Remission of diabetes while on sunitinib treatment for renal cell carcinoma
A. Templeton et al.
ANNALS OF ONCOLOGY (2008)
MAPK p38 regulates transcriptional activity of NF-κB in primary human astrocytes via acetylation of p65
Ramendra N. Saha et al.
JOURNAL OF IMMUNOLOGY (2007)
IκB kinase β phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-κB pathway
Jessica E. Hutti et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias
Taira Maekawa et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2007)
Amelioration of diabetes by imatinib mesylate (Gleevec®):: role of β-cell NF-κB activation and anti-apoptotic preconditioning
Robert Hagerkvist et al.
FASEB JOURNAL (2007)
LIND/ABIN-3 is a novel lipopolysaccharide-inducible inhibitor of NF-κB activation
Andy Wullaert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Imatinib mesylate (Gleevec) protects against streptozotocin-induced diabetes and islet cell death in vitro
Robert Hagerkvist et al.
CELL BIOLOGY INTERNATIONAL (2006)
Improvement of type 2 diabetes in a lung cancer patient treated with erlotinib
Daniel B. Costa et al.
DIABETES CARE (2006)
Extracellular signal-regulated kinase is essential for interleukin-1-induced and nuclear factor κB-mediated gene expression in insulin-producing INS-1E cells
L Larsen et al.
DIABETOLOGIA (2005)
Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes -: Many differences, few similarities
M Cnop et al.
DIABETES (2005)
Successful islet transplantation from a single pancreas harvested from a young, low-BMI, non-heart-beating cadaver
T Goto et al.
TRANSPLANTATION PROCEEDINGS (2005)
Targeting apoptosis pathways in cancer therapy
IM Ghobrial et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Imatinib and regression of type 2 diabetes
D Veneri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Imatinib mesylate may improve fasting blood glucose in diabetic Ph plus chronic myelogenous leukemia patients responsive to treatment
M Breccia et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Suppressor of cytokine signalling (SOCS)-3 protects beta cells against IL-1β-mediated toxicity through inhibition of multiple nuclear factor-κB-regulated proapoptotic pathways
AE Karlsen et al.
DIABETOLOGIA (2004)
NF-κB signalling is inhibited by glucocorticoid receptor and STAT6 via distinct mechanisms
G Nelson et al.
JOURNAL OF CELL SCIENCE (2003)
NF-κB in cancer:: From innocent bystander to major culprit
M Karin et al.
NATURE REVIEWS CANCER (2002)
A choice of death - the signal-transduction of immune-mediated beta-cell apoptosis
DL Eizirik et al.
DIABETOLOGIA (2001)
分享论文
